These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. PBMs' rebate income threatened by lawsuits and move to generics. Sipkoff M Manag Care; 2008 Mar; 17(3):11-2. PubMed ID: 18447152 [No Abstract] [Full Text] [Related]
3. Competition between brand-name and generics--analysis on pricing of brand-name pharmaceutical. Kong Y Health Econ; 2009 May; 18(5):591-606. PubMed ID: 18816580 [TBL] [Abstract][Full Text] [Related]
4. Branded drug reformulation: the next brand vs. generic antitrust battleground. Amoresano GV Food Drug Law J; 2007; 62(1):249-56. PubMed ID: 17444032 [No Abstract] [Full Text] [Related]
5. Trade agreements, intellectual property, and the role of the World Bank in improving access to medicines in developing countries. Rovira J Yale J Health Policy Law Ethics; 2004; 4(2):401-13. PubMed ID: 15536921 [No Abstract] [Full Text] [Related]
6. Generic boost. Bill, acquisitions could help hospitals save money. Rhea S Mod Healthc; 2009 Apr; 39(16):17. PubMed ID: 19419134 [No Abstract] [Full Text] [Related]
7. Price regulation and generic competition in the pharmaceutical market. Dalen DM; Strøm S; Haabeth T Eur J Health Econ; 2006 Sep; 7(3):208-14. PubMed ID: 16841230 [TBL] [Abstract][Full Text] [Related]
8. Australia-United States Free Trade Agreement and the Australian Pharmaceutical Benefits Scheme. Sainsbury P Yale J Health Policy Law Ethics; 2004; 4(2):387-99. PubMed ID: 15536920 [No Abstract] [Full Text] [Related]
9. Generic drug price war begins to benefit insurers. Sipkoff M Manag Care; 2009 Jan; 18(1):9-10. PubMed ID: 19186663 [No Abstract] [Full Text] [Related]
10. The impact of generic substitution on price competition in Finland. Aalto-Setälä V Eur J Health Econ; 2008 May; 9(2):185-91. PubMed ID: 17508226 [TBL] [Abstract][Full Text] [Related]
11. Competition and antitrust enforcement in the changing pharmaceutical marketplace. Whitener MD Food Drug Law J; 1995; 50(2):301-7. PubMed ID: 10342998 [No Abstract] [Full Text] [Related]
12. When is a brand a generic? In a contract with a PBM. Cahn LJ Manag Care; 2010 Sep; 19(9):21-5. PubMed ID: 20931886 [No Abstract] [Full Text] [Related]
15. Pricing of drugs with heterogeneous health insurance coverage. Ferrara I; Missios P J Health Econ; 2012 Mar; 31(2):440-56. PubMed ID: 22484368 [TBL] [Abstract][Full Text] [Related]
16. Barrier to trade or barrier to profit? Why Australia's Pharmaceutical Benefits Scheme worries U.S. drug companies. Hamilton C; Lokuge B; Denniss R Yale J Health Policy Law Ethics; 2004; 4(2):373-85. PubMed ID: 15536919 [No Abstract] [Full Text] [Related]
19. Folly or volley? Will a dollar $4 pill finally open the healthcare market to competitive pricing? Sturm AC Healthc Financ Manage; 2006 Nov; 60(11):120-2. PubMed ID: 17094287 [No Abstract] [Full Text] [Related]
20. Wal-Mart rolls out its own health-care reform. Yang JL Fortune; 2006 Mar; 153(5):30. PubMed ID: 16584107 [No Abstract] [Full Text] [Related] [Next] [New Search]